[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100587219":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":20,"locations":26,"responsibleParty":235,"collaborators":19,"id":237,"slug":238,"hasResults":239,"nctId":240,"briefTitle":241,"officialTitle":242,"acronym":19,"eligibilityCriteria":243,"healthyVolunteers":239,"sex":244,"minAge":245,"maxAge":246,"enrollmentInfo":247,"targetDuration":19,"studyType":250,"phases":251,"briefSummary":253,"conditions":254,"keywords":262,"overallStatus":29,"whyStopped":19,"lastUpdateSubmitDate":278,"lastUpdatePostDateStruct":279,"startDateStruct":282,"completionDateStruct":284,"leadSponsor":286,"locationsCount":287},{"fullName":5,"class":6},"CRISPR Therapeutics","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"CTX112","EXPERIMENTAL","Administered by IV infusion following lymphodepleting chemotherapy",[13],"Biological: CTX112",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"BIOLOGICAL","CTX112 (CD19-directed T-cell immunotherapy comprised of allogeneic T cells genetically modified ex vivo using CRISPR-Cas9 gene editing components)",[9],null,[21],{"name":22,"role":23,"phone":24,"phoneExt":19,"email":25},"Clinical Trials","CONTACT","1 877-214-4634","medicalaffairs@crisprtx.com",[27,47,64,81,96,111,128,141,155,167,179,191,211,223],{"facility":28,"status":29,"city":30,"state":31,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"Stanford University Medical Center","RECRUITING","Redwood City","California","94063","United States","US",{"type":36,"coordinates":37},"Point",[38,39],-122.23635,37.48522,{"lat":39,"lon":38},[42,45],{"name":43,"role":23,"phone":19,"phoneExt":19,"email":44},"Sally Arai, MD","sarai1@stanford.edu",{"name":43,"role":46,"phone":19,"phoneExt":19,"email":19},"PRINCIPAL_INVESTIGATOR",{"facility":48,"status":29,"city":49,"state":50,"zip":51,"country":33,"countryCode":34,"cosmosGeoPoint":52,"geoPoint":56,"contacts":57},"Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center","Chicago","Illinois","63110",{"type":36,"coordinates":53},[54,55],-87.65005,41.85003,{"lat":55,"lon":54},[58,62],{"name":59,"role":23,"phone":60,"phoneExt":19,"email":61},"Kaitlin King","312-695-0990","Autoimmunesct@nm.org",{"name":63,"role":46,"phone":19,"phoneExt":19,"email":19},"George Georges, MD",{"facility":65,"status":29,"city":66,"state":67,"zip":68,"country":33,"countryCode":34,"cosmosGeoPoint":69,"geoPoint":73,"contacts":74},"University of Iowa","Iowa City","Iowa","52242",{"type":36,"coordinates":70},[71,72],-91.53017,41.66113,{"lat":72,"lon":71},[75,79],{"name":76,"role":23,"phone":77,"phoneExt":19,"email":78},"Ashley Pieper","319-356-0765","ashley-pieper@uiowa.edu",{"name":80,"role":46,"phone":19,"phoneExt":19,"email":19},"Hanna Zembrzuska, MD",{"facility":82,"status":29,"city":83,"state":84,"zip":85,"country":33,"countryCode":34,"cosmosGeoPoint":86,"geoPoint":90,"contacts":91},"Manning Family Children's Hospital of New Orleans","New Orleans","Louisiana","70118",{"type":36,"coordinates":87},[88,89],-90.07507,29.95465,{"lat":89,"lon":88},[92,95],{"name":93,"role":23,"phone":19,"phoneExt":19,"email":94},"Anita Dhanrajani, MD","adhanrajani@tulane.edu",{"name":93,"role":46,"phone":19,"phoneExt":19,"email":19},{"facility":97,"status":29,"city":98,"state":99,"zip":100,"country":33,"countryCode":34,"cosmosGeoPoint":101,"geoPoint":105,"contacts":106},"Boston Medical Center","Boston","Massachusetts","02118",{"type":36,"coordinates":102},[103,104],-71.05977,42.35843,{"lat":104,"lon":103},[107,110],{"name":108,"role":23,"phone":19,"phoneExt":19,"email":109},"Hanni Menn-Josephy, MD","Hanni.Menn@bmc.org",{"name":108,"role":46,"phone":19,"phoneExt":19,"email":19},{"facility":112,"status":29,"city":113,"state":114,"zip":115,"country":33,"countryCode":34,"cosmosGeoPoint":116,"geoPoint":120,"contacts":121},"Washington University School of Medicine","St Louis","Missouri","63130",{"type":36,"coordinates":117},[118,119],-90.19789,38.62727,{"lat":119,"lon":118},[122,126],{"name":123,"role":23,"phone":124,"phoneExt":19,"email":125},"Emily Green","314-273-0339","green.e@wustl.edu",{"name":127,"role":46,"phone":19,"phoneExt":19,"email":19},"Alfred Kim, MD",{"facility":129,"status":29,"city":130,"state":131,"zip":132,"country":33,"countryCode":34,"cosmosGeoPoint":133,"geoPoint":137,"contacts":138},"University of North Carolina TraCS Institute - CTRC","Chapel Hill","North Carolina","27599",{"type":36,"coordinates":134},[135,136],-79.05584,35.9132,{"lat":136,"lon":135},[139],{"name":140,"role":46,"phone":19,"phoneExt":19,"email":19},"Saira Sheikh",{"facility":142,"status":29,"city":143,"state":19,"zip":144,"country":145,"countryCode":146,"cosmosGeoPoint":147,"geoPoint":151,"contacts":152},"University of Augsburg","Augsburg","86156","Germany","DE",{"type":36,"coordinates":148},[149,150],10.89851,48.37154,{"lat":150,"lon":149},[153],{"name":154,"role":46,"phone":19,"phoneExt":19,"email":19},"Christoph Schmid",{"facility":156,"status":29,"city":157,"state":19,"zip":158,"country":145,"countryCode":146,"cosmosGeoPoint":159,"geoPoint":163,"contacts":164},"Universitätsklinikum Köln","Cologne","50937",{"type":36,"coordinates":160},[161,162],6.95,50.93333,{"lat":162,"lon":161},[165],{"name":166,"role":46,"phone":19,"phoneExt":19,"email":19},"Philip Kohler",{"facility":168,"status":29,"city":169,"state":19,"zip":170,"country":145,"countryCode":146,"cosmosGeoPoint":171,"geoPoint":175,"contacts":176},"Medizinische Hochschule Hannover (MHH)","Hanover","30625",{"type":36,"coordinates":172},[173,174],9.73322,52.37052,{"lat":174,"lon":173},[177],{"name":178,"role":46,"phone":19,"phoneExt":19,"email":19},"Christian Schultze-Florey",{"facility":180,"status":29,"city":181,"state":19,"zip":182,"country":145,"countryCode":146,"cosmosGeoPoint":183,"geoPoint":187,"contacts":188},"UCT University Medical Center Mainz","Mainz","55131",{"type":36,"coordinates":184},[185,186],8.28008,49.98185,{"lat":186,"lon":185},[189],{"name":190,"role":46,"phone":19,"phoneExt":19,"email":19},"Eva Wagner-Drouet",{"facility":192,"status":29,"city":193,"state":19,"zip":194,"country":195,"countryCode":196,"cosmosGeoPoint":197,"geoPoint":201,"contacts":202},"Hospital Universitario Reina Sofia","Córdoba","14004","Spain","ES",{"type":36,"coordinates":198},[199,200],-4.77275,37.89155,{"lat":200,"lon":199},[203,206,209],{"name":204,"role":23,"phone":19,"phoneExt":19,"email":205},"Maria Angeles Aguirre","angeles.aguirre.sspa@juntadeandalucia.es",{"name":207,"role":23,"phone":19,"phoneExt":19,"email":208},"Maria del Carmen Ábalos","mcarmen.abalos@imibic.org",{"name":210,"role":46,"phone":19,"phoneExt":19,"email":19},"Maria Angeles Aguirre, MD",{"facility":212,"status":29,"city":213,"state":19,"zip":214,"country":195,"countryCode":196,"cosmosGeoPoint":215,"geoPoint":219,"contacts":220},"Clinica Universidad de Navarra - Pamplona","Pamplona","31008",{"type":36,"coordinates":216},[217,218],-1.64323,42.81687,{"lat":218,"lon":217},[221],{"name":222,"role":46,"phone":19,"phoneExt":19,"email":19},"Ornilla Ornilla, MD",{"facility":224,"status":29,"city":225,"state":19,"zip":226,"country":195,"countryCode":196,"cosmosGeoPoint":227,"geoPoint":231,"contacts":232},"Hospital Universitario Virgen del Rocio","Seville","41013",{"type":36,"coordinates":228},[229,230],-5.97317,37.38283,{"lat":230,"lon":229},[233],{"name":234,"role":46,"phone":19,"phoneExt":19,"email":19},"Elena Alonso Blanco-Morales, MD",{"type":236,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100587219","phase-1-a-safety-and-efficacy-study-evaluating-ctx112-in-adult-subjects-with-refractory-autoimmune-disease-100587219",false,"NCT06925542","A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease","A Phase 1 Dose Evaluation Study of the Safety and Preliminary Efficacy of Anti-CD19 Allogeneic CRISPR-Cas9-Engineered T Cells (CTX112) in Adult Subjects With Refractory Autoimmune Disease","Key Inclusion Criteria:\n\n1. Age ≥18 years and \\\u003C 70 years of age.\n2. Subjects must voluntarily sign a written informed consent and be willing and able to comply with all study requirements.\n3. Adequate hematologic, renal, liver, cardiac and pulmonary organ function.\n4. Subjects must agree to use acceptable methods of contraception.\n5. Willing and able to comply with scheduled visits, treatment plan, laboratory tests, contraceptive guidelines, and other study procedures.\n6. Diagnosis of systemic lupus erythematosus (SLE), systemic sclerosis (SSc) or idiopathic inflammatory myopathy (IIM).\n\nFor systemic lupus erythematosus (SLE) subjects:\n\n\\- Diagnosis of SLE by a board-certified rheumatologist that conforms with 2019 ACR\u002FEULAR criteria. For lupus nephritis subjects, active, biopsy-proven proliferative lupus nephritis Class III or IV, either with or without the presence of Class V, and appropriate National Institutes of Health index activity score using the 2018 International Society of Nephrology\u002FRenal Pathology Society criteria.\n\nFor Systemic Sclerosis (SSc) subjects:\n\n\\- Diagnosis of diffuse cutaneous systemic sclerosis (dcSSC) or SSc-ILD that conforms with 2013 ACR\u002FEULAR criteria. Subjects should meet active skin or lung disease criteria.\n\nFor Idiopathic Inflammatory Myopathy (IIM) subjects:\n\n\\- Diagnosis with dermatomyositis (DM), polymyositis (PM) or myositis as part of rheumatologic overlap syndrome, antisynthetase (ASyS), or immune-mediated necrotizing myopathy (IMNM) that conforms with 2017 ACR\u002FEULAR criteria for inflammatory myopathies. Subjects must meet moderate severe, skin, or lung involvement criteria.\n\nKey Exclusion Criteria:\n\n1. Prior anti-CD19 therapy or any gene therapy\u002Fgenetically modified cell therapy.\n2. Prior solid organ (heart, liver, kidney, lung) transplant or hematopoietic cell transplant.\n3. Severe active or history of central nervous (CNS) involvement.\n4. History of a seizure disorder, cerebrovascular ischemia\u002Fhemorrhage, dementia, cerebellar disease or any autoimmune disease with CNS involvement other than SLE, SSc or IIM.\n5. Mixed connective tissue disease with no clear predominant disease.\n6. Presence of study disease manifestations or other conditions that are likely to pose increase safety risks and\u002For confound disease assessments, or pose significant risk to those receiving CAR T cell therapy.\n7. History of primary or secondary immunodeficiency.\n8. Presence or history of certain bacterial, viral or fungal infection.\n9. Malignancy in the last 5 years (with the exception of cancers deemed to be low likelihood for recurrence).\n10. Diagnosis of a genetic disorder associated with bone marrow failure or myelodysplastic syndrome.\n11. History or current diagnosis of catastrophic anti-phospholipid syndrome or anti phospholipid syndrome that requires ongoing anticoagulation.\n12. Pregnant or lactating.\n13. Presence or history of disease requiring treatment that is not compatible with the study protocol; presence or history of other conditions that are not compatible with the study protocol.","ALL","18 Years","70 Years",{"count":248,"type":249},80,"ESTIMATED","INTERVENTIONAL",[252],"PHASE1","This is a single-arm, open-label, multicenter, ascending dose Phase 1 study evaluating the safety and preliminary efficacy of CTX112 in adult subjects with refractory autoimmune diseases, including active systemic lupus erythematosus (SLE), systemic sclerosis (SSc), or idiopathic inflammatory myopathy (IIM).",[255,256,257,258,259,260,261],"SLE (Systemic Lupus)","Lupus Erythematosus, Systemic","Lupus Nephritis","Systemic Sclerosis","Inflammatory Myopathy, Idiopathic","Myositis","Diffuse Cutaneous Systemic Sclerosis",[263,264,265,257,266,267,268,269,260,270,271,272,273,274,275,276,277],"CAR T","Lupus","SLE","Allogeneic","CD19","Cell Therapy","Scleroderma","Systemic sclerosis","Idiopathic Inflammatory Myopathy","Inflammatory Myopathy","Diffused Cutaneous Systemic Sclerosis","Gene Therapy","Autoimmune","SSc","IIM","2026-08-05",{"date":280,"type":281},"2026-08-07","ACTUAL",{"date":283,"type":281},"2025-03-10",{"date":285,"type":249},"2031-12-31",{"name":5,"class":6},14]